Compounds

Details for Australian Patent Application No. 2005260143 (hide)

Owner AstraZeneca AB

Inventors Gabos, Balint; Stenvall, Kristina; Ripa, Lena

Agent Freehills

Pub. Number AU-B-2005260143

PCT Pub. Number WO2006/004533

Priority 0401763-8 05.07.04 SE

Filing date 4 July 2005

Wipo publication date 12 January 2006

Acceptance publication date 29 January 2009

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4166 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07D 233/72 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/004533 Priority application(s): WO2006/004533

29 January 2009 Application Accepted

  Published as AU-B-2005260143

28 May 2009 Standard Patent Sealed

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005260146-Method for producing molecularly imprinted polymers

2005260142-Novel hydantoin derivatives for the treatment of obstructive airway diseases